NCT01411280View on ClinicalTrials.gov

Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Sickle Cell Disease
Interventions
DRUG

methylphenidate

Ritalin 10mg, Ritalin 20mg

Trial Locations (2)

19140

Temple University, Philadelphia

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Temple University

OTHER

NCT01411280 - Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD) | Biotech Hunter | Biotech Hunter